Posters by Presenters \ Lokesh Viswanath
| 1 results found. Displaying results 1 to 1. |
A Phase IIb, 4-arm, open-label, randomized, multi-center study to assess the safety and efficacy of radiation/chemoradiation therapy in combination with the novel anti-EGFR monoclonal antibody h-R3 in patients with advanced (stage III or IVa) inoperable h
Category : Head/Neck / 2009Presenter : Lokesh Viswanath
| 1 results found. Displaying results 1 to 1. |